Log in to save to my catalogue

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid m...

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid m...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_736a839a8b974bd3b3e8b75fc5cd0d0b

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model

About this item

Full title

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model

Publisher

England: BioMed Central Ltd

Journal title

Journal of neuroinflammation, 2025-03, Vol.22 (1), p.66-16, Article 66

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

HIV-1-associated neurocognitive impairment (HIV-1-NCI) is marked by ongoing and chronic neuroinflammation with loss and decline in neuronal function even when antiretroviral drug therapy (ART) successfully suppresses viral replication. Microglia, the primary reservoirs of HIV-1 in the central nervous system (CNS), play a significant role in maintai...

Alternative Titles

Full title

Antiretroviral drug therapy does not reduce neuroinflammation in an HIV-1 infection brain organoid model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_736a839a8b974bd3b3e8b75fc5cd0d0b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_736a839a8b974bd3b3e8b75fc5cd0d0b

Other Identifiers

ISSN

1742-2094

E-ISSN

1742-2094

DOI

10.1186/s12974-025-03375-w

How to access this item